1. LudvigssonJF, LefflerDA, BaiJC, et al.The Oslo definitions for coeliac disease and related terms. Gut2013;62:43. CrossRef

2. SollidLM, JabriB. Is celiac disease an autoimmune disorder?Curr Opin Immunol2005;17:595. CrossRef

3. AccomandoS, CataldoF. The global village of celiac disease. Dig Liver Dis2004;36:492. CrossRef

4. Rubio‐TapiaA, LudvigssonJF, BrantnerTL, et al.The prevalence of celiac disease in the United States. Am J Gastroenterol2012;107:1538. CrossRef

5. FasanoA, BertiI, GerarduzziT, et al.Prevalence of celiac disease in at‐risk and not‐at‐risk groups in the United States: a large multicenter study. Arch Intern Med2003;163:286. CrossRef

6. MustalahtiK, CatassiC, ReunanenA, et al.The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med2010;42:587. CrossRef

7. AlaridaK, HarownJ, AhmaidaA, et al.Coeliac disease in Libyan children: a screening study based on the rapid determination of anti‐transglutaminase antibodies. Dig Liver Dis2011;43:688. CrossRef

8. DalgicB, SariS, BasturkB, et al.Prevalence of celiac disease in healthy Turkish school children. Am J Gastroenterol2011;106:1512. CrossRef

9. CumminsAG, Roberts‐ThomsonIC. Prevalence of celiac disease in the Asia‐Pacific region. J Gastroenterol Hepatol2009;24:1347. CrossRef

10. BhattacharyaM, DubeyAP, MathurNB. Prevalence of celiac disease in north Indian children. Indian Pediatr2009;46:415.

11. MakhariaGK, VermaAK, AmarchandR, et al.Prevalence of celiac disease in the northern part of India: a community based study. J Gastroenterol Hepatol2011;26:894. CrossRef

12. YachhaSK, PoddarU. Celiac disease in India. Indian J Gastroenterol2007;26:230.

13. TalleyNJ, ValdovinosM, PettersonTM, et al.Epidemiology of celiac sprue: a community‐based study. Am J Gastroenterol1994;89:843.

14. Rubio‐TapiaA, HillID, KellyCP, et al.; American College of Gastroenterology. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol2013;108:656, quiz 77. CrossRef

15. Rubio‐TapiaA, LudvigssonJF, BrantnerTL, et al.The prevalence of celiac disease in the United States. Am J Gastroenterol2012;107:1538; quiz 7, 45. CrossRef

16. LohiS, MustalahtiK, KaukinenK, et al.Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther2007;26:1217. CrossRef

17. Rubio‐TapiaA, KyleRA, KaplanEL, et al.Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology2009;137:88. CrossRef

18. SchuppanD, JunkerY, BarisaniD. Celiac disease: from pathogenesis to novel therapies. Gastroenterology2009;137:1912. CrossRef

19. PlengeRM. Unlocking the pathogenesis of celiac disease. Nat Genet2010;42:281. CrossRef

20. SollidLM, JabriB. Celiac disease and transglutaminase 2: a model for posttranslational modification of antigens and HLA association in the pathogenesis of autoimmune disorders. Curr Opin Immunol2011;23:732. CrossRef

21. PlattSG, KasardaDD. Separation and characterization of ‐gliadin fractions. Biochim Biophys Acta1971;243:407. CrossRef

22. CamarcaA, AndersonRP, MamoneG, et al.Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide‐based therapy in celiac disease. J Immunol2009;182:4158. CrossRef

23. GassJ, BethuneMT, SiegelM, et al.Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue. Gastroenterology2007;133:472. CrossRef

24. MolbergO, UhlenAK, JensenT, et al.Mapping of gluten T‐cell epitopes in the bread wheat ancestors: implications for celiac disease. Gastroenterology2005;128:393. CrossRef

25. BethuneMT, SiegelM, Howles‐BanerjiS, et al.Interferon‐gamma released by gluten‐stimulated celiac disease‐specific intestinal T cells enhances the transepithelial flux of gluten peptides. J Pharmacol Exp Ther2009;329:657. CrossRef

26. ZimmerKP, PorembaC, WeberP, et al.Translocation of gliadin into HLA‐DR antigen containing lysosomes in coeliac disease enterocytes. Gut1995;36:703. CrossRef

27. van de WalY, KooyY, van VeelenP, et al.Selective deamidation by tissue transglutaminase strongly enhances gliadin‐specific T cell reactivity. J Immunol1998;161:1585.

28. PietzakMM, SchofieldTC, McGinnissTJ, et al.Stratifying risk for celiac disease in a large at‐risk US population using HLA alleles. Clin Gastroenterol Hepatol2009;7:966. CrossRef

29. QiaoSW, SollidLM, BlumbergRS. Antigen presentation in celiac disease. Curr Opin Immunol2009;21:111. CrossRef

30. GarnerCP, MurrayJA, DingYC, et al.Replication of celiac disease UK genome‐wide association study results in a US population. Hum Mol Genet2009;18:4219. CrossRef

31. JabriB, KasardaDD, GreenPH. Innate and adaptive immunity: the yin and yang of celiac disease. Immunol Rev2005;206:219. CrossRef

32. DieterichW, EhnisT, BauerM, et al.Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med1997;3:797. CrossRef

33. HadjivassiliouM, MakiM, SandersDS, et al.Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia. Neurology2006;66:373. CrossRef

34. MariettaEV, CamilleriMJ, CastroLA, et al.Transglutaminase autoantibodies in dermatitis herpetiformis and celiac sprue. J Invest Dermatol2008;128:332.

35. AnjumN, BakerPN, RobinsonNJ, et al.Maternal celiac disease autoantibodies bind directly to syncytiotrophoblast and inhibit placental tissue transglutaminase activity. Reprod Biol Endocrinol2009;7:16. CrossRef

36. SalmiTT, CollinP, JarvinenO, et al.Immunoglobulin A autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming coeliac disease. Aliment Pharmacol Ther2006;24:541. CrossRef

37. OberhuberG. Histopathology of celiac disease. Biomed Pharmacother2000;54:368. CrossRef

38. PallavK, LefflerDA, TariqS, et al.Noncoeliac enteropathy: the differential diagnosis of villous atrophy in contemporary clinical practice. Aliment Pharmacol Ther2012;35:380. CrossRef

39. ChangF, MahadevaU, DeereH. Pathological and clinical significance of increased intraepithelial lymphocytes (IELs) in small bowel mucosa. APMIS2005;113:385. CrossRef

40. ShahVH, RotterdamH, KotlerDP, et al.All that scallops is not celiac disease. Gastrointest Endosc2000;51:717. CrossRef

41. CranneyA, ZarkadasM, GrahamID, et al.The Canadian Celiac Health Survey. Dig Dis Sci2007;52:1087. CrossRef

42. GreenPHR, StavropoulosSN, PanagiSG, et al.Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol2001;96:126. CrossRef

43. SteneLC, HoneymanMC, HoffenbergEJ, et al.Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol2006;101:2333. CrossRef

44. LewyH, MeirsonH, LaronZ. Seasonality of birth month of children with celiac disease differs from that in the general population and between sexes and is linked to family history and environmental factors. J Pediatr Gastroenterol Nutr2009;48:181. CrossRef

45. ShahS, LefflerD. Celiac disease: an underappreciated issue in women's health. Womens Health (Lond Engl)2010;6:753. CrossRef

46. JammaS, Rubio‐TapiaA, KellyCP, et al.Celiac crisis is a rare but serious complication of celiac disease in adults. Clin Gastroenterol Hepatol2010;8:587. CrossRef

47. FasanoA. Celiac disease–how to handle a clinical chameleon. N Engl J Med2003;348:2568. CrossRef

48. FarrellRJ, KellyCP. Celiac sprue. N Engl J Med2002;346:180. CrossRef

49. LudvigssonJF, LefflerDA, BaiJC, et al.The Oslo definitions for coeliac disease and related terms. Gut2013;62:43. CrossRef

50. GreenPH, CellierC. Celiac disease. N Engl J Med2007;357:1731. CrossRef

51. FasanoA, CatassiC. Coeliac disease in children. Best Pract Res Clin Gastroenterol2005;19:467. CrossRef

52. BartonSH, KellyDG, MurrayJA. Nutritional deficiencies in celiac disease. Gastroenterol Clin North Am2007;36:93, vi. CrossRef

53. SimpsonS, ThompsonT. Nutrition assessment in celiac disease. Gastrointest Endosc Clin N Am2012;22:797. CrossRef

54. LefflerDA, SchuppanD. Update on serologic testing in celiac disease. Am J Gastroenterol2010;105:2520. CrossRef

55. ShamirR, HernellO, LeshnoM. Cost‐effectiveness analysis of screening for celiac disease in the adult population. Med Decis Making2006;26:282. CrossRef

56. DornSD, MatcharDB. Cost‐effectiveness analysis of strategies for diagnosing celiac disease. Dig Dis Sci2008;53:680. CrossRef

57. NIH Consensus Development Conference on Celiac Disease. NIH Consens State Sci Statements2004;21:1.

58. AbergAK, OlcenP. Serologic screening for celiac disease in children: a comparison between established assays and tests with deamidated gliadin‐derived peptides plus conjugates for both IgA and IgG antibodies. APMIS2009;117:808. CrossRef

59. LudvigssonJF, MontgomerySM, EkbomA, et al.Small‐intestinal histopathology and mortality risk in celiac disease. JAMA2009;302:1171. CrossRef

60. LefflerD, VangaR, MukherjeeR. Mild enteropathy celiac disease: a wolf in sheep's clothing?Clin Gastroenterol Hepatol2013;11:259. CrossRef

61. SollidLM, ThorsbyE. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology1993;105:910.

62. TennysonCA, CiaccioEJ, LewisSK. Video capsule endoscopy in celiac disease. Gastrointest Endosc Clin N Am2012;22:747. CrossRef

63. RondonottiE, VillaF, SaladinoV, et al.Enteroscopy in the diagnosis and management of celiac disease. Gastrointest Endosc Clin N Am2009;19:445. CrossRef

64. LefflerD, SchuppanD, PallavK, et al.Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease. Gut2013;62:996. CrossRef

65. SchuppanD, DennisMD, KellyCP. Celiac disease: epidemiology, pathogenesis, diagnosis, and nutritional management. Nutr Clin Care2005;8:54.

66. HogbergL, LaurinP, Falth‐MagnussonK, et al.Oats to children with newly diagnosed coeliac disease: a randomised double blind study. Gut2004;53:649. CrossRef

67. JanatuinenEK, KemppainenTA, PikkarainenPH, et al.Lack of cellular and humoral immunological responses to oats in adults with coeliac disease. Gut2000;46:327. CrossRef

68. HoffenbergEJ, HaasJ, DrescherA, et al.A trial of oats in children with newly diagnosed celiac disease. J Pediatr2000;137:361. CrossRef

69. JanatuinenEK, KemppainenTA, JulkunenRJ, et al.No harm from five year ingestion of oats in coeliac disease. Gut2002;50:332. CrossRef

70. TheethiraTG, DennisM, LefflerDA. Nutritional consequences of celiac disease and the gluten‐free diet. Expert Rev Gastroenterol Hepatol2014;8:123. CrossRef

71. WingrenCJ, AgardhD, MerloJ. Revisiting the risk of celiac disease in children born small for gestational age: a sibling design perspective. Scand J Gastroenterol2012;47:632. CrossRef

72. HallertC, GrantC, GrehnS, et al.Evidence of poor vitamin status in coeliac patients on a gluten‐free diet for 10 years. Aliment Pharmacol Ther2002;16:1333. CrossRef

73. ThompsonT, DennisM, HigginsLA, et al.Gluten‐free diet survey: are Americans with coeliac disease consuming recommended amounts of fibre, iron, calcium and grain foods?J Hum Nutr Diet2005;18:163. CrossRef

74. ThompsonT. Thiamin, riboflavin, and niacin contents of the gluten‐free diet: is there cause for concern?J Am Diet Assoc1999;99:858. CrossRef

75. LeeAR, NgDL, ZivinJ, et al.Economic burden of a gluten‐free diet. J Hum Nutr Diet2007;20:423. CrossRef

76. LefflerDA, DennisM, HyettB, et al.Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol2007;5:445. CrossRef

77. HermanML, Rubio‐TapiaA, LahrBD, et al.Patients with celiac disease are not followed up adequately. Clin Gastroenterol Hepatol2012;10:893. CrossRef

78. LeeAR, NgDL, DiamondB, et al.Living with coeliac disease: survey results from the USA. J Hum Nutr Diet2012;25:233. CrossRef

79. LefflerDA, Edwards‐GeorgeJ, DennisM, et al.Factors that influence adherence to a gluten‐free diet in adults with celiac disease. Dig Dis Sci2008;53:1573. CrossRef

80. MahadevS, SimpsonS, LebwohlB, et al.Is dietitian use associated with celiac disease outcomes?Nutrients2013;5:1585. CrossRef

81. BarrattSM, LeedsJS, SandersDS. Quality of life in Coeliac Disease is determined by perceived degree of difficulty adhering to a gluten‐free diet, not the level of dietary adherence ultimately achieved. J Gastrointestin Liver Dis2011;20:241.

82. KabbaniTA, GoldbergA, KellyCP, et al.Body mass index and the risk of obesity in coeliac disease treated with the gluten‐free diet. Aliment Pharmacol Ther2012;35:723. CrossRef

83. AbidN, McGloneO, CardwellC, et al.Clinical and metabolic effects of gluten free diet in children with type 1 diabetes and coeliac disease. Pediatr Diabetes2011;12:322. CrossRef

84. ReillyNR, AguilarK, HassidBG, et al.Celiac disease in normal‐weight and overweight children: clinical features and growth outcomes following a gluten‐free diet. J Pediatr Gastroenterol Nutr2011;53:528.

85. LebwohlB, GranathF, EkbomA, et al.Mucosal healing and mortality in coeliac disease. Aliment Pharmacol Ther2013;37:332. CrossRef

86. Rubio‐TapiaA, RahimMW, SeeJA, et al.Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten‐free diet. Am J Gastroenterol2010;105:1412. CrossRef

87. BiagiF, CorazzaGR. Mortality in celiac disease. Nat Rev Gastroenterol Hepatol2010;7:158. CrossRef

88. DennisC, KupperC, LeeAR, et al., American Dietetics Association. Celiac Disease Evidence Based Nutrition Practice Guideline, 2009. Available at: http://www.adaevidencelibrary.com/topic.cfm?cat=3677. Accessed April 2011.

89. BaiJC, FriedM, CorazzaGR, et al.World Gastroenterology Organisation Practice Guidelines on Celiac Disease, 2007. Available at: http://www.worldgastroenterology.org/assets/downloads/en/pdf/guidelines/04_celiac_disease.pdf. Accessed April 2011.

90. AGA Institute. AGA Institute medical position statement on the diagnosis and management of celiac disease. Gastroenterology2006;131:1977. CrossRef

91. HusbyS, KoletzkoS, Korponay‐SzaboIR, et al.European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr2012;54:136. CrossRef

92. AbdulkarimAS, BurgartLJ, SeeJ, et al.Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol2002;97:2016. CrossRef

93. FineKD, MeyerRL, LeeEL. The prevalence and causes of chronic diarrhea in patients with celiac sprue treated with a gluten‐free diet. Gastroenterology1997;112:1830. CrossRef

94. AbdallahH, LefflerD, DennisM, et al.Refractory celiac disease. Curr Gastroenterol Rep2007;9:401. CrossRef

95. RoshanB, LefflerDA, JammaS, et al.The incidence and clinical spectrum of refractory celiac disease in a north american referral center. Am J Gastroenterol2011;106:923. CrossRef

96. Rubio‐TapiaA, KellyDG, LahrBD, et al.Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology2009;136:99; quiz 352. CrossRef

97. TrierJS, FalchukZM, CareyMC, et al.Celiac sprue and refractory sprue. Gastroenterology1978;75:307.

98. CellierC, DelabesseE, HelmerC, et al.Refractory sprue, coeliac disease, and enteropathy‐associated T‐cell lymphoma. French Coeliac Disease Study Group. Lancet2000;356:203. CrossRef

99. DaumS, IpczynskiR, HeineB, et al.Therapy with budesonide in patients with refractory sprue. Digestion2006;73:60. CrossRef

100. BrarP, LeeS, LewisS, et al.Budesonide in the treatment of refractory celiac disease. Am J Gastroenterol2007;102:2265. CrossRef

101. JammaS, LefflerDA, DennisM, et al.Small intestinal release mesalamine for the treatment of refractory celiac disease type I. J Clin Gastroenterol2011;45:30. CrossRef

102. ElsingC, PlackeJ, Gross‐WeegeW. Ulcerative jejunoileitis and enteropathy‐associated T‐cell lymphoma. Eur J Gastroenterol Hepatol2005;17:1401. CrossRef

103. HolmesG, PriorP, LaneM, et al.Malignancy in coeliac disease‐effect of a gluten‐free diet. Gut1989;30:333. CrossRef

104. CorraoG, CorazzaG, BagnardiV, et al.Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet2001;358:356. CrossRef

105. AsklingJ, LinetM, GridleyG, et al.Cancer incidence in a population‐based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology2002;123:1428. CrossRef

106. CatassiC, FabianiE, CorraoG, et al.Risk of non‐Hodgkin lymphoma in celiac disease. JAMA2002;287:1413. CrossRef

107. Cerf‐BensussanN, CellierC, HeymanM, et al.Coeliac disease: an update on facts and questions based on the 10th International Symposium on Coeliac Disease. J Pediatr Gastroenterol Nutr2003;37:412. CrossRef

108. SpencerJ, Cerf‐BensussanN, JarryA, et al.Enteropathy‐associated T cell lymphoma (malignant histiocytosis of the intestine) is recognized by a monoclonal antibody (HML‐1) that defines a membrane molecule on human mucosal lymphocytes. Am J Pathol1988;132:1. CrossRef

109. MurrayA, CuevasE, JonesD, et al.Study of the immunohistochemistry and T cell clonality of enteropathy‐associated T cell lymphoma. Am J Pathol1995;146:509.

110. Ashton‐KeyM, DissT, PanL, et al.Molecular analysis of T‐cell clonality in ulcerative jejunitis and enteropathy‐associated T‐cell lymphoma. Am J Pathol1997;151:493.

111. FreemanH, ChiuB. Small bowel malignant lymphoma complicating celiac sprue and the mesenteric lymph node cavitation syndrome. Gastroenterology1986;90:2008.

112. MatuchanskyC, ColinR, HemetJ, et al.Cavitation of mesenteric lymph nodes, splenic atrophy, and a flat small intestinal mucosa: report of six cases. Gastroenterology1984;87:606.

113. EganL, WalshS, StevensF, et al.Celiac‐associated lymphoma: a single‐institution experience of 30 cases in the combination chemotherapy era. J Clin Gastroenterol1995;21:123. CrossRef

114. MukherjeeR, KellyCP, SchuppanD. Nondietary therapies for celiac disease. Gastrointest Endosc Clin N Am2012;22:811. CrossRef

115. SiegelM, GarberME, SpencerAG, et al.Safety, tolerability, and activity of ALV003: results from two phase 1 single, escalating‐dose clinical trials. Dig Dis Sci2012;57:440. CrossRef

116. TripathiA, LammersKM, GoldblumS, et al.Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin‐2. Proc Natl Acad Sci U S A2009;106:16799. CrossRef

117. LefflerDA, KellyCP, AbdallahHZ, et al.A randomized, double‐blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge. Am J Gastroenterol2012;107:1554. CrossRef

118. KellyCP, GreenPH, MurrayJA, et al.Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo‐controlled study. Aliment Pharmacol Ther2013;37:252. CrossRef

119. MolbergO, McAdamS, LundinKE, et al.T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase. Eur J Immunol2001;31:1317. CrossRef

120. EspositoC, CaputoI, TronconeR. New therapeutic strategies for coeliac disease: tissue transglutaminase as a target. Curr Med Chem2007;14:2572. CrossRef

121. KapoerchanVV, WiesnerM, HillaertU, et al.Design, synthesis and evaluation of high‐affinity binders for the celiac disease associated HLA‐DQ2 molecule. Mol Immunol2010;47:1091. CrossRef

122. Rubio‐TapiaA. Seguimiento médico del paciente celiaco. RodrigoL, PeñaAS(eds). Enfermedad Celíaca y Sensibilidad al Gluten no Celíaca. Barcelona, España: OmniaScience; 2013: 377.